175 results
Page 3 of 9
8-K/A
EX-10.1
jbncgw ig8r
21 Nov 18
Departure of Directors or Certain Officers
4:10pm
425
EX-10.2
4uhi 0kb1nm0
21 Sep 18
Business combination disclosure
4:06pm
425
EX-10.3
yu980ma57zl3ckide7
21 Sep 18
Business combination disclosure
4:06pm
425
EX-10.1
b3o92yfz0a8 yl1yy
21 Sep 18
Business combination disclosure
4:06pm
8-K
EX-10.1
vz1as3f1efqx8 n0s
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.3
vvr52 nnxq
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.2
861ggjv
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.1
s1hrstk8ahg yjk
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
gq3nugd4fj
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
wfme1fgz0
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm
8-K
EX-10.1
5rk vz62u5macc
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
EX-10.1
l549i6 c4c3q77t
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
20y 0nyfofy01li8a8x
27 Apr 18
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
9:26am